Prolongation of graft survival in the concordant hamster-to-rat cardiac model.
Brouard
S
S
Itert Inserm, Nantes, France.
Blancho
G
G
Moreau
A
A
Heslan
J M
JM
Cuturi
M C
MC
Soulillou
J P
JP
D000818:Animals; D003169:Complement Inactivator Proteins / Q000627:therapeutic use; D006224:Cricetinae; D016572:Cyclosporine / Q000627:therapeutic use; D016207:Cytokines / Q000235:genetics; D004546:Elapid Venoms / Q000627:therapeutic use; D006085:Graft Survival; D016027:Heart Transplantation / Q000276:immunology / Q000473:pathology / Q000502:physiology*; D007041:Hypoxanthine Phosphoribosyltransferase / Q000235:genetics; D008647:Mesocricetus; D012333:RNA, Messenger / Q000096:biosynthesis; D051381:Rats; D011917:Rats, Inbred Lew; D014158:Transcription, Genetic; D014183:Transplantation, Heterologous / Q000276:immunology / Q000473:pathology / Q000502:physiology*
D003169:Complement Inactivator Proteins; D016207:Cytokines; D004546:Elapid Venoms; D012333:RNA, Messenger; C016310:cobra venom factor; D016572:Cyclosporine; D007041:Hypoxanthine Phosphoribosyltransferase